Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Blueprint Medicines Corp (BPMC)
Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Blueprint Medicines Corp 45 SIDNEY STREET CAMBRIDGE MA 02139 USA

www.blueprintmedicines.com P: 617-374-7580

Description:

Blueprint Medicines Corporation is a biopharmaceutical company focused on developing the potentially transformational precision medicines to address patients with genomically defined cancers and rare diseases.

Key Statistics

Overview:

Market Capitalization, $K 4,162,900
Enterprise Value, $K 4,182,270
Shares Outstanding, K 60,790
Annual Sales, $ 204,040 K
Annual Net Income, $ -557,520 K
Last Quarter Sales, $ 56,570 K
Last Quarter Net Income, $ -133,710 K
EBIT, $ -530,970 K
EBITDA, $ -520,220 K
60-Month Beta 0.62
% of Insider Shareholders 3.88%
Float, K 58,431
% Float 96.12%
Short Volume Ratio 0.26

Growth:

1-Year Return 53.97%
3-Year Return -32.69%
5-Year Return 21.18%
5-Year Revenue Growth 852.12%
5-Year Earnings Growth -138.52%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.20 on 10/26/23
Next Earnings Date N/A
Earnings Per Share ttm -9.19
EPS Growth vs. Prev Qtr -0.46%
EPS Growth vs. Prev Year 1.35%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BPMC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -153.79%
Return-on-Assets % -46.40%
Profit Margin % -273.24%
Net Margin % N/A
Debt/Equity 0.39
Price/Sales 20.37
Price/Cash Flow N/A
Price/Book 20.74
Book Value/Share 3.33
Interest Coverage -1.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar